The Utah Innovation Fund, a state-backed venture capital fund, has made a collective $700,000 investment in three healthcare and life sciences startups. The companies are 3Helix, part of the University of Utah’s startup portfolio; Rebel Medicine, founded by a UofU graduate; and Inherent Biosciences, a joint development between the UofU and Brigham Young University.
“The Utah Innovation Fund is deeply committed to fostering the advancement of pioneering technologies, and these companies have made significant strides in the field of biomedical innovation,” said Gabi Tellez, managing director for the Utah Innovation Fund.
Jefferson Moss, Innovation Fund managing director said, “We want to make an impact with the Please log in to see the rest of this story.
